“…There is growing evidence that alterations in NMDA receptor signaling play a role in ASD and other neurodevelopmental disorders (for recent reviews, see Burnashev et al 2015; Lee et al 2015), including reports that autism candidate genes, such as NEUROLIGIN-1 and SHANK3 , serve as regulators of NMDA receptor function (Budreck et al 2013; Duffney et al 2013). Mice with reduced Grin1 expression recapitulate many ASD features, including overt social deficits, inappropriate social interaction, abnormal repetitive behavior, self-injurious responses, and impaired sensorimotor gating (Billingslea et al 2014; Duncan et al, 2004, Finlay et al 2015; Gandal et al, 2012, Milenkovic et al, 2014; Mohn et al, 1999, Moy et al, 2008a, 2012, 2014; Saunders et al 2013). We determined the effects of oxytocin on social deficits, reduced prepulse inhibition, and hyperactivity in Grin1 knockdown mice.…”